Moteur de recherche d’entreprises européennes

Propriétaire ultime Ler 26/10/2026 Global Legal Entity Identifier Foundation (Relationships)

Vue d’ensemble

Texte

Relationship Record

This record details a relationship between two legal entities, identified by their Legal Entity Identifiers (LEIs).

Relationship Details

Field Value
Relationship Type IS_ULTIMATELY_CONSOLIDATED_BY
Relationship Status ACTIVE

Start Node

Field Value
Node ID 5493003EJXH8XA8L9095
Node ID Type LEI

End Node

Field Value
Node ID 5493000HZTVUYLO1D793
Node ID Type LEI

Relationship Periods

Start Date End Date Period Type
2025-01-01T00:00:00Z 2025-12-31T00:00:00Z ACCOUNTING_PERIOD
2023-01-01T00:00:00Z RELATIONSHIP_PERIOD

Relationship Qualifiers

Qualifier Dimension Qualifier Category
ACCOUNTING_STANDARD OTHER_ACCOUNTING_STANDARD

Registration Details

Field Value
Initial Registration Date 2016-02-13T02:20:00Z
Last Update Date 2026-10-26T17:28:30.693Z
Registration Status PUBLISHED
Next Renewal Date 2027-09-12T00:00:00Z
Managing LOU 213800WAVVOPS85N2205
Validation Sources FULLY_CORROBORATED
Validation Documents ACCOUNTS_FILING
Validation Reference https://www.gsk.com/media/kn0bknmd/annual-report-2025.pdf

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Glaxosmithkline Research & Development Ltd., Londres, Royaume Uni.